Literature DB >> 8536716

Involvement of Janus kinases in the insulin signaling pathway.

S Giorgetti-Peraldi1, F Peyrade, V Baron, E Van Obberghen.   

Abstract

The adaptor molecule growth-factor-receptor-bound protein-2 (Grb2) plays a role in insulin action since it links tyrosine phosphorylated IRS-1 and Shc to the guanine-nucleotide-exchange factor, Sos, which initiates the mitogen-activated-protein (MAP) kinase cascade by producing Ras-GTP. Both IRS-1 and Shc are phosphorylated by the insulin-receptor tyrosine kinase. In the present study, we have investigated whether the tyrosine kinases of the Janus kinase family (JAK) could be involved in insulin signaling by acting on Grb2. In fibroblasts over-expressing insulin receptors we observed that two tyrosine-phosphorylated proteins interact with Grb2 and with a mutant of Grb2, which lacks the Src homology 2 (SH2) domain, indicating that these proteins associate with the SH3 domains of Grb2. Further, we found that both JAK1 and JAK2 constitutively associate with Grb2, through interaction with the SH3 domains of Grb2. Finally, insulin appears to induce the tyrosine phosphorylation of JAK1, but does not modify the tyrosine phosphorylation state of JAK2. In conclusion, our results suggest that the JAK proteins could participate in insulin signal transduction, and could therefore constitute an alternative pathway for mediating some of the pleiotropic responses induced by insulin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8536716     DOI: 10.1111/j.1432-1033.1995.656_b.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

Review 1.  Novel roles for insulin receptor (IR) in adipocytes and skeletal muscle cells via new and unexpected substrates.

Authors:  Latha Ramalingam; Eunjin Oh; Debbie C Thurmond
Journal:  Cell Mol Life Sci       Date:  2012-10-10       Impact factor: 9.261

2.  Stat5 is a physiological substrate of the insulin receptor.

Authors:  J Chen; H B Sadowski; R A Kohanski; L H Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

3.  Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons.

Authors:  A Meinke; F Barahmand-Pour; S Wöhrl; D Stoiber; T Decker
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

4.  The mitogen-activated protein kinome from Anopheles gambiae: identification, phylogeny and functional characterization of the ERK, JNK and p38 MAP kinases.

Authors:  Ashley A Horton; Bo Wang; Lauren Camp; Mark S Price; Arora Arshi; Mate Nagy; Steven A Nadler; James R Faeder; Shirley Luckhart
Journal:  BMC Genomics       Date:  2011-11-23       Impact factor: 3.969

5.  Molecular basis of signaling specificity of insulin and IGF receptors: neglected corners and recent advances.

Authors:  Kenneth Siddle
Journal:  Front Endocrinol (Lausanne)       Date:  2012-02-28       Impact factor: 5.555

6.  Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation.

Authors:  Y Kawazoe; T Naka; M Fujimoto; H Kohzaki; Y Morita; M Narazaki; K Okumura; H Saitoh; R Nakagawa; Y Uchiyama; S Akira; T Kishimoto
Journal:  J Exp Med       Date:  2001-01-15       Impact factor: 14.307

7.  Downregulation of the Ubiquitin Ligase RNF125 Underlies Resistance of Melanoma Cells to BRAF Inhibitors via JAK1 Deregulation.

Authors:  Hyungsoo Kim; Dennie T Frederick; Mitchell P Levesque; Zachary A Cooper; Yongmei Feng; Clemens Krepler; Laurence Brill; Yardena Samuels; Nicholas K Hayward; Ally Perlina; Adriano Piris; Tongwu Zhang; Ruth Halaban; Meenhard M Herlyn; Kevin M Brown; Jennifer A Wargo; Reinhard Dummer; Keith T Flaherty; Ze'ev A Ronai
Journal:  Cell Rep       Date:  2015-05-28       Impact factor: 9.423

8.  IGF-1-induced MMP-11 expression promotes the proliferation and invasion of gastric cancer cells through the JAK1/STAT3 signaling pathway.

Authors:  Chao Su; Wenchang Wang; Cunchuan Wang
Journal:  Oncol Lett       Date:  2018-03-12       Impact factor: 2.967

9.  Baricitinib counteracts metaflammation, thus protecting against diet-induced metabolic abnormalities in mice.

Authors:  Debora Collotta; William Hull; Raffaella Mastrocola; Fausto Chiazza; Alessia Sofia Cento; Catherine Murphy; Roberta Verta; Gustavo Ferreira Alves; Giulia Gaudioso; Francesca Fava; Magdi Yaqoob; Manuela Aragno; Kieran Tuohy; Christoph Thiemermann; Massimo Collino
Journal:  Mol Metab       Date:  2020-05-13       Impact factor: 7.422

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.